Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men
- PMID: 28684611
- PMCID: PMC5723541
- DOI: 10.1136/sextrans-2016-053063
Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men
Abstract
Background: Trichomonasvaginalis (TV) is a highly prevalent parasitic infection worldwide. It is associated with many adverse reproductive health outcomes. Many infections are asymptomatic and syndromic management leads to underdetection of TV. Traditional methods of TV detection such as wet preparation are insensitive. New rapid, point-of-care (POC) tests can enhance the diagnosis of trichomoniasis.
Methods: The authors reviewed the literature and discuss older POC tests for TV detection, as well as the OSOM lateral flow test, the AmpliVue test, the Solana test and the GeneXpert test as well as the limitations of wet preparation and culture for detection of TV.
Results: The OSOM test is easy to perform, compared with other POC tests, and is Clinical Laboratory Improvement Amendments (CLIA)-waived, equipment-free, has sensitivities of 83%-86% compared with nucleic acid amplification tests (NAATs) and can be performed in 15 min. The AmpliVue and the Solana tests are not CLIA waived and require small pieces of equipment. They are molecular amplified assays and can be completed in <1 hour. AmpliVue demonstrated a sensitivity for vaginal swabs of 100% compared with wet preparation/culture and 90.7% compared with NAATs. Solana demonstrated a sensitivity of 98.6%-100% for vaginal swabs and 92.9%-98% for female urines, compared with wet preparation/culture. Compared with other NAATs, the sensitivity for Solana was 89.7% for swabs and 100% for urine. The GeneXpert TV test for women and men is a moderately complex test, requires a small platform and can be performed in <1 hour. The sensitivity compared with wet preparation/culture for self-collected vaginal swabs was 96.4%, 98.9% for endocervical specimens and 98.4% for female urine. For men, sensitivity for urines was excellent (97.2%). The specificity for all assays was excellent.
Conclusions: Several rapid POC tests have the potential to rapidly diagnose trichomoniasis in women and one is available for detection of TV in men.
Keywords: DNA amplification; Diagnosis; Genital tract infect; Testing; Trichomonas.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.Expert Rev Mol Diagn. 2017 Mar;17(3):303-306. doi: 10.1080/14737159.2017.1282823. Epub 2017 Jan 29. Expert Rev Mol Diagn. 2017. PMID: 28092466 Free PMC article. Clinical Trial.
-
Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.Sex Transm Dis. 2016 Jun;43(6):369-73. doi: 10.1097/OLQ.0000000000000447. Sex Transm Dis. 2016. PMID: 27196258 Free PMC article.
-
Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.J Clin Microbiol. 2018 Jan 24;56(2):e01091-17. doi: 10.1128/JCM.01091-17. Print 2018 Feb. J Clin Microbiol. 2018. PMID: 29167292 Free PMC article.
-
APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.Expert Rev Mol Diagn. 2011 Sep;11(7):679-88. doi: 10.1586/erm.11.53. Expert Rev Mol Diagn. 2011. PMID: 21902528 Review.
-
Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis.Crit Rev Microbiol. 2016 May;42(3):406-17. doi: 10.3109/1040841X.2014.958050. Epub 2014 Nov 10. Crit Rev Microbiol. 2016. PMID: 25383648 Review.
Cited by
-
Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection.Pathogens. 2023 Jan 3;12(1):77. doi: 10.3390/pathogens12010077. Pathogens. 2023. PMID: 36678425 Free PMC article.
-
WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances.APMIS. 2018 Dec;126(12):907-912. doi: 10.1111/apm.12902. APMIS. 2018. PMID: 30456870 Free PMC article.
-
Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?Clin Infect Dis. 2018 Jul 2;67(2):218-220. doi: 10.1093/cid/ciy085. Clin Infect Dis. 2018. PMID: 29554227 Free PMC article. No abstract available.
-
Emerging Designs of Electronic Devices in Biomedicine.Micromachines (Basel). 2020 Jan 22;11(2):123. doi: 10.3390/mi11020123. Micromachines (Basel). 2020. PMID: 31979030 Free PMC article. Review.
-
Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections.Int J Environ Res Public Health. 2021 Jan 25;18(3):1038. doi: 10.3390/ijerph18031038. Int J Environ Res Public Health. 2021. PMID: 33503917 Free PMC article. Review.
References
-
- World Health Organization DoRhaR. Global incidence and prevalence of selected curabe sexually transmitted infections-2008. Geneva: WHO; 2012. [accessed 28 sep 2015]. pp. 1–20.
-
- Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187–93. - PubMed
-
- Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with Low Birth Weight and Preterm delivery. Sex Transm Dis. 1997;24:353–60. - PubMed
-
- Silver BJ, Guy RJ, Kaldor JM, et al. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41:369–76. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources